In addition, many studies have shown that serum carbohydrate antigen 72-4 (CA72-4), carcinoembryonic antigen (CEA), and carbohydrate antigen 19-9 (CA19-9) can be used as biomarkers for early GC diagnosis [3, 6–8]. This evidence concerns the gene CEACAM5 and gastric cancer.